Human Thrombin Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Human Thrombin Market size is expected to grow at an annual average CAGR of 2% during 2022-2028. Thrombin is a serine protease enzyme encoded by a specific gene called F2 and is used to convert fibrinogen (soluble) into fibrin (insoluble). This transition mimics the final coagulation cascade stage, which involves clotting masses that adhere to the wound surface and achieve hemostasis and open tissue occlusion. Human thrombin is a sterile solution, pH 6.8-7.2, containing highly purified human thrombin for coagulation activation. Human thrombin is used in several medical surgeries for the management of uncontrolled bleeding. It is also used in diagnostic centers and clinics for a variety of applications such as coagulation analysis, defibrillation of blood or plasma, and testing of clotting factors.

The following segmentation are covered in this report:

By Application

• Hospital
• Clinic
• Other

By Type

• 500IU
• 1000IU
• 2500IU

Company Profile

• Baxter International, Inc.
• Bayer AG
• BD Biosciences
• CSL Behring
• Life Technologies Corporation
• Pfizer Inc.
• PromoCell GmbH
• Sigma-Aldrich Corporation
• Vitrolife AB

Scope of the report

The research study analyses the Human Thrombin Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Human Thrombin Market Report

• What was the Human Thrombin Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Human Thrombin Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.